Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: The MIB-1 labeling index is the most effective parameter

被引:0
|
作者
Yoshifumi Saito
Yasushi Matsuzaki
Mikio Doi
Takehiko Sugitani
Toshiya Chiba
Masato Abei
Junichi Shoda
Naomi Tanaka
机构
[1] Departments of Internal Medicine,
[2] Tsukuba Medical Center,undefined
[3] 1-3-1 Amakubo,undefined
[4] Tsukuba,undefined
[5] Ibaraki 305,undefined
[6] Japan,undefined
[7] Division of Gastroenterology,undefined
[8] Institute of Clinical Medicine,undefined
[9] University of Tsukuba,undefined
[10] 1-1-1 Tennodai,undefined
[11] Tsukuba,undefined
[12] Ibaraki 305,undefined
[13] Japan,undefined
[14] Departments of Pathology,undefined
[15] Tsukuba Medical Center,undefined
[16] 1-3-1 Amakubo,undefined
[17] Tsukuba,undefined
[18] Ibaraki 305,undefined
[19] Japan,undefined
来源
关键词
Key words: HCC; tumor volume doubling time MIB-1 monoclonal antibody;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to clarify whether histological parameters reflected tumor aggressiveness in patients with hepatocellular carcinoma (HCC). The tumor volume doubling times (TVDTs) of 21 HCCs, less than 3 cm in diameter at the start of the observation period, were calculated in 21 patients in whom the natural progression of the lesion was observed by ultrasonography. Paraffin-embedded sections were prepared from samples obtained by ultrasound-guided fine-needle liver biopsy at the end of the observation period. The histological parameters examined were the MIB-1 labeling index (LI), for which we performed immunohistochemical staining with the MIB-1 monoclonal antibody, using an antigen retrieval method; the nucleo-cytoplasmic (N/C ratio), cellularity, and the nuclear form factor (NFF), were calculated with an imaging analyzer. We performed multiple regression analysis for estimating the growth of small HCCs. With the N/C ratio (0.154 ± 0.068; mean ± SD), cellularity (453 ± 21.8 cells/104 μm2), NFF (1.150 ± 0.096), and degree of HCC differentiation as independent variables, only the MIB-1 LI (11.8 ± 6.1%) showed a significant correlation with TVDT (207.5 ± 162.6 days) (r = −0.658; P < 0.05). Compared to the conventional indices of histological atypism tested, i.e., N/C ratio, cellularity NFF, and degree of HCC differentiation, only MIB-1 LI was significantly correlated with small HCC growth rate. The MIB-1 LI may therefore be a simple and useful index of tumor aggressiveness.
引用
收藏
页码:229 / 235
页数:6
相关论文
共 21 条
  • [1] Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: The MIB-1 labeling index is the most effective parameter
    Saito, Y
    Matsuzaki, Y
    Doi, M
    Sugitani, T
    Chiba, T
    Abei, M
    Shoda, J
    Tanaka, N
    JOURNAL OF GASTROENTEROLOGY, 1998, 33 (02) : 229 - 235
  • [2] Low MIB-1 labeling index in anti-HCV positive hepatocellular carcinoma
    Watanuki, A
    Ohwada, S
    Fukusato, T
    Kawate, S
    Makita, F
    Morishita, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (05) : 1017 - 1022
  • [3] MULTIPLE-REGRESSION ANALYSIS FOR ESTIMATING THE GROWTH OF SMALL HEPATOCELLULAR-CARCINOMA - CELL PROLIFERATIVE ACTIVITY IS THE MOST EFFECTIVE PARAMETER
    SAITO, Y
    MATSUZAKI, Y
    DOY, M
    IKEGAMI, T
    SATO, M
    SUGITANI, T
    CHIBA, T
    ABEI, M
    SHODA, J
    TANAKA, N
    NAKANO, M
    GASTROENTEROLOGY, 1995, 108 (04) : A1161 - A1161
  • [4] The MIB-1/Caspase labeling index as a predictor of metastasis to the brain in patients with non-small cell lung carcinoma
    Saad, A. G.
    Thunnissen, F. B.
    Pinkus, G. S.
    Pinkus, J. L.
    Chirieac, L. R.
    MODERN PATHOLOGY, 2007, 20 : 330A - 330A
  • [5] The MIB-1/caspase labeling index as a predictor of metastasis to the brain in patients with non-small cell lung carcinoma
    Saad, A. G.
    Thunnissen, F. B.
    Pinkus, G. S.
    Pinkus, J. L.
    Chirieac, L. R.
    LABORATORY INVESTIGATION, 2007, 87 : 330A - 330A
  • [6] Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination
    Ogawa, Yoshikazu
    Sugawara, Takayuki
    Seki, Hirobumi
    Sakuma, Tutomu
    JOURNAL OF NEURO-ONCOLOGY, 2006, 79 (02) : 211 - 216
  • [7] Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination
    Yoshikazu Ogawa
    Takayuki Sugawara
    Hirobumi Seki
    Tutomu Sakuma
    Journal of Neuro-Oncology, 2006, 79 : 211 - 216
  • [8] Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining
    Kritpracha, K
    Hanprasertpong, J
    Chandeying, V
    Dechsukhum, C
    Geater, A
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2005, 31 (03) : 268 - 276
  • [9] MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix
    Ho, DMT
    Hsu, CY
    Chiang, H
    GYNECOLOGIC ONCOLOGY, 2000, 76 (01) : 97 - 102
  • [10] MIB-1 labeling index is useful as prognostic and predictive markers for adjuvant therapy in non-small cell lung cancer
    Yanagawa, N.
    Osakabe, M.
    Ogata, S-Y.
    Shiono, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 12 - 13